BioPhorum Strengthens Position in Biopharma with Brookwood Global Acquisition

BioPhorum has announced its acquisition of Brookwood Global, a UK-based provider of training and educational content for clinical research professionals. BioPhorum, a key player in the biopharmaceutical industry for over 15 years, is renowned for fostering collaboration among industry leaders to drive innovation and improve patient outcomes. The acquisition of Brookwood Global, a private company that has delivered professional development solutions in clinical research and drug safety to over 100,000 professionals from around 120 countries since 1996, marks a significant expansion for BioPhorum.

BioPhorum CEO Deborah Kobewka expressed her enthusiasm about the acquisition, highlighting how Brookwood’s digital training expertise complements BioPhorum’s deep knowledge of the biopharmaceutical and life sciences sectors. This partnership will enable both organizations to diversify and grow, with BioPhorum gaining the opportunity to expand its unique offerings into new segments of the pharmaceutical value chain. Kobewka emphasized that this collaboration will empower BioPhorum members to reach broader audiences with innovative solutions and practical training resources, benefitting their organizations and the industry at large.

Brookwood Global’s Founder, Professor Dr. David Hutchinson, also welcomed the acquisition, praising BioPhorum's collaborative approach with leading life sciences companies. He expressed eagerness to integrate Brookwood’s expertise with BioPhorum’s operations, anticipating valuable synergies that will enhance the services provided to their collective customers.